Crescent Capital BDC (CCAP) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
17 Nov, 2025Executive summary
Net investment income (NII) was $0.46 per share, unchanged from the prior quarter, while net income per share declined to $0.19 from $0.41 sequentially.
Net asset value (NAV) per share decreased to $19.28 from $19.55, mainly due to unrealized and realized losses from portfolio companies affected by tariffs.
Portfolio remains highly diversified with $1.6 billion in investments across 187 companies, with 90% in first-lien or unitranche first lien loans and 99% of the debt portfolio sponsor-backed.
Board declared a regular Q4 dividend of $0.42 per share, marking the 39th consecutive quarter of earning the regular dividend, and paid a final special dividend of $0.05 per share for Q3 2025.
Specialty finance company focused on U.S. middle-market debt, with $1.6 billion in total assets and $714 million in net assets as of September 30, 2025.
Financial highlights
Net income for the quarter was $0.19 per share, down from $0.41 in the prior quarter, reflecting higher net realized and unrealized losses of $(0.27) per share.
Weighted average yield of income-producing securities at cost remained stable at 10.4% quarter-over-quarter.
Non-accruals as a percentage of investments at fair value improved from 2.4% to 1.6% quarter-over-quarter.
Gross deployment in the quarter totaled $74 million, with $51 million in new platform investments and $22 million in incremental investments.
Sufficient liquidity with $27.8 million in cash and $239.8 million undrawn debt capacity at quarter end.
Outlook and guidance
Anticipates lower base rate environment may reduce portfolio yields and pressure NII, but expects to cover the base dividend with NII in the near term.
Expects increased origination and structuring fees, and higher non-interest-related income as deal activity picks up.
Sees a larger opportunity set for new investments over the next 12 months, supported by a robust origination pipeline.
Variable supplemental distribution framework remains in effect.
Board declared a Q4 2025 regular cash dividend of $0.42 per share, consistent with prior quarters.
Latest events from Crescent Capital BDC
- Q4 net investment income covered the dividend, with NAV at $19.10 and a defensively positioned portfolio.CCAP
Q4 202526 Feb 2026 - Q2 2024 NII reached $0.59/share, NAV $20.30, with strong liquidity and stable credit.CCAP
Q2 20241 Feb 2026 - Q3 net investment income rose to $0.64 per share, with strong liquidity and low non-accruals.CCAP
Q3 202414 Jan 2026 - Q4 2024 featured lower NII, stable NAV, robust liquidity, and special dividends for 2025.CCAP
Q4 202424 Dec 2025 - Board urges ratification of Ernst & Young LLP as auditor, with 2024 fees totaling $841,150.CCAP
Proxy Filing2 Dec 2025 - Director elections and auditor ratification headline the 2025 annual meeting agenda.CCAP
Proxy Filing2 Dec 2025 - Stockholders will vote virtually on director elections and auditor ratification, with strong board oversight.CCAP
Proxy Filing2 Dec 2025 - Net investment income and NAV per share fell, but dividends and portfolio quality remain strong.CCAP
Q1 202526 Nov 2025 - Q2 2025 delivered strong income, stable NAV, and a $20M share repurchase program.CCAP
Q2 202523 Nov 2025